Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Grüter

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Scientific Reports|July 27, 2021
Corneal inflammatory cell infiltration predicts disease activity in chronic inflammatory demyelinating polyneuropathyJeremias Motte, Thomas Grüter, Anna Lena Fisse, et al.
Journal of Neurology|January 8, 2025
Early therapy initiation is crucial in chronic inflammatory demyelinating polyneuropathy: prospective multimodal data from the German INHIBIT registryAurelian Schumacher, Alina Hieke, Marie Spenner, et al.
Neurology|October 25, 2023
In Vivo Measurement of Tau Depositions in Anti-IgLON5 Disease Using [18F]PI-2620 PETHendrik Theis, Gérard N Bischof, Norbert Brüggemann, et al.
European Journal of Neurology|March 31, 2022
Prevalence and determinants of pain in chronic inflammatory demyelinating polyneuropathy: Results from the German INHIBIT registryHannah Mork, Jeremias Motte, Anna Lena Fisse, et al.
Frontiers in Neurology|January 24, 2024
Comparative analysis of albumin quotient and total CSF protein in immune-mediated neuropathies: a multicenter study on diagnostic implicationsTabea Seeliger, Stefan Gingele, Yunus Emre Güzeloglu, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2023
Propionate exerts neuroprotective and neuroregenerative effects in the peripheral nervous systemThomas Grüter, Nuwin Mohamad, Niklas Rilke, et al.
Therapeutic Advances in Neurological Disorders|March 22, 2021
Treatment response to cyclophosphamide, rituximab, and bortezomib in chronic immune-mediated sensorimotor neuropathies: a retrospective cohort studyJeremias Motte, Anna Lena Fisse, Nuray Köse, et al.
European Journal of Neurology|January 11, 2024
Association of the neonatal Fc receptor promoter variable number of tandem repeat polymorphism with immunoglobulin response in patients with chronic inflammatory demyelinating polyneuropathyAnna Lena Fisse, Emelie Schäfer, Alina Hieke, et al.
Cells|July 13, 2026
TRPV1 Agonist Capsaicin Enhances Oxidative-Stress Resistance and Regeneration in Dorsal Root Ganglia and Schwann CellsBaffour Kyei Sarpong, Niklas Rilke, Lea Joswig, et al.
Journal of Neurology|May 29, 2024
The multiple roles of nerve biopsy in the diagnosis and prognosis of suspected immune neuropathiesRafael Klimas, Anna Kordes, Sophie Huckemann, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Scientific Reports|July 27, 2021
Corneal inflammatory cell infiltration predicts disease activity in chronic inflammatory demyelinating polyneuropathyJeremias Motte, Thomas Grüter, Anna Lena Fisse, et al.
Journal of Neurology|January 8, 2025
Early therapy initiation is crucial in chronic inflammatory demyelinating polyneuropathy: prospective multimodal data from the German INHIBIT registryAurelian Schumacher, Alina Hieke, Marie Spenner, et al.
Neurology|October 25, 2023
In Vivo Measurement of Tau Depositions in Anti-IgLON5 Disease Using [18F]PI-2620 PETHendrik Theis, Gérard N Bischof, Norbert Brüggemann, et al.
European Journal of Neurology|March 31, 2022
Prevalence and determinants of pain in chronic inflammatory demyelinating polyneuropathy: Results from the German INHIBIT registryHannah Mork, Jeremias Motte, Anna Lena Fisse, et al.
Frontiers in Neurology|January 24, 2024
Comparative analysis of albumin quotient and total CSF protein in immune-mediated neuropathies: a multicenter study on diagnostic implicationsTabea Seeliger, Stefan Gingele, Yunus Emre Güzeloglu, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2023
Propionate exerts neuroprotective and neuroregenerative effects in the peripheral nervous systemThomas Grüter, Nuwin Mohamad, Niklas Rilke, et al.
Therapeutic Advances in Neurological Disorders|March 22, 2021
Treatment response to cyclophosphamide, rituximab, and bortezomib in chronic immune-mediated sensorimotor neuropathies: a retrospective cohort studyJeremias Motte, Anna Lena Fisse, Nuray Köse, et al.
European Journal of Neurology|January 11, 2024
Association of the neonatal Fc receptor promoter variable number of tandem repeat polymorphism with immunoglobulin response in patients with chronic inflammatory demyelinating polyneuropathyAnna Lena Fisse, Emelie Schäfer, Alina Hieke, et al.
Cells|July 13, 2026
TRPV1 Agonist Capsaicin Enhances Oxidative-Stress Resistance and Regeneration in Dorsal Root Ganglia and Schwann CellsBaffour Kyei Sarpong, Niklas Rilke, Lea Joswig, et al.
Journal of Neurology|May 29, 2024
The multiple roles of nerve biopsy in the diagnosis and prognosis of suspected immune neuropathiesRafael Klimas, Anna Kordes, Sophie Huckemann, et al.
Pageof 6